Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinici… (NCT07485491) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational Calls
United States60 participantsStarted 2026-06
Plain-language summary
The goal of this clinical trial is to determine if a behavioral intervention can increase attendance at cardiac rehabilitation (CR) after secondary/type 2 myocardial infarction in adult patients. The main question it aims to answer is:
* Does the ATTEND-CR intervention increase attendance at ≥1 CR exercise session within 140 days of randomization?
* Does the intervention increase completion of ≥12 CR exercise sessions within 140 days of randomization?
Researchers will compare participants receiving the ATTEND-CR intervention (clinician notifications and a motivational interviewing participant phone call) to usual care to see if attendance and completion of CR improve.
Participants:
* Clinicians will receive informational messaging regarding CR and the referral process
* Participate in a motivational interviewing phone call (intervention group only)
* Have follow-up assessments via telephone and electronic health record (EHR) review to track CR attendance, clinical events, and health outcomes
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years
* Inpatient at MGH with an index secondary (type 2) MI
* Primary care provider (PCP) within the Mass General Brigham (MGB) network with at least one visit in the past 2 years
* Anticipated ability to ambulate independently without walking aids or supplemental ambulatory oxygen at discharge
* Ability to provide informed consent
Exclusion Criteria:
* Known severe untreated valvular heart disease or severe prosthetic valve dysfunction
* Known hypertrophic obstructive cardiomyopathy
* End-stage heart failure (VAD, transplant patient, or undergoing evaluation for VAD or transplant)
* Hemodynamic instability at the time of pre-screening
* Terminal illness with life expectancy \< 1 year
* Severe anemia (hemoglobin \< 8 g/dL) at the time of pre-screening
* Active, unstable cancer (excluding non-metastatic skin cancer) or currently receiving intensive cancer therapy
* Advanced kidney disease requiring renal replacement therapy
* Receiving palliative or comfort care only
* Recurrent falls (≥2) or falls with injury in the past year
* Physical or cognitive impairment likely to prevent safe participation in exercise over the next 5 months (e.g., significant stroke deficits, dementia)
* High-risk for non-adherence to study requirements
* Incarcerated individuals
* Currently pregnant or within 3 months postpartum
* Previously referred to or participated in CR within the past year
* Alternative MI subtype (spontaneous \[type 1 MI\] or procedural MI \[t…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of Participants Who Attended one or more Cardiac Rehabilitation Exercise Session
Timeframe: Within 140 days (inclusive) post-randomization